SEC Form 4 · accession 0001140361-15-011534

Emergent BioSolutions Inc. · EBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Biodefense Divison

Period of report

Mar 10, 2015

Accepted (ET)

Mar 12, 2015 · 5:02 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001367644

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1,F2	Mar 10, 2015	A	9,313	$0.00	A	44,671	D
Common Stock^F1	Mar 10, 2015	F	1,535	$29.00	D	43,136	D
Common Stock^F1	Mar 11, 2015	F	1,278	$28.99	D	41,858	D
Common Stock^F1	Mar 12, 2015	F	785	$28.67	D	41,073	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F3	$28.99	Mar 10, 2015	A	18,620	A	—	Mar 9, 2022	Common Stock	18,620	18,620	D

F1Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
F2These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
F3Vests in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018.